Amalgamated Bank’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Buy |
38,824
+501
| +1% | +$18K | 0.01% | 921 |
|
2025
Q1 | $1.51M | Sell |
38,323
-1,082
| -3% | -$42.7K | 0.01% | 884 |
|
2024
Q4 | $1.19M | Sell |
39,405
-123
| -0.3% | -$3.7K | 0.01% | 992 |
|
2024
Q3 | $925K | Buy |
39,528
+34,660
| +712% | +$811K | 0.01% | 1079 |
|
2024
Q2 | $87K | Buy |
4,868
+310
| +7% | +$5.54K | ﹤0.01% | 1741 |
|
2024
Q1 | $69K | Sell |
4,558
-15,241
| -77% | -$231K | ﹤0.01% | 1791 |
|
2023
Q4 | $338K | Sell |
19,799
-916
| -4% | -$15.6K | ﹤0.01% | 1593 |
|
2023
Q3 | $173K | Hold |
20,715
| – | – | ﹤0.01% | 1834 |
|
2023
Q2 | $515K | Buy |
20,715
+1,833
| +10% | +$45.6K | ﹤0.01% | 1425 |
|
2023
Q1 | $284K | Sell |
18,882
-2,316
| -11% | -$34.8K | ﹤0.01% | 1663 |
|
2022
Q4 | $251K | Hold |
21,198
| – | – | ﹤0.01% | 1770 |
|
2022
Q3 | $125K | Buy |
21,198
+340
| +2% | +$2.01K | ﹤0.01% | 2052 |
|
2022
Q2 | $89K | Sell |
20,858
-262
| -1% | -$1.12K | ﹤0.01% | 2213 |
|
2022
Q1 | $201K | Sell |
21,120
-1,602
| -7% | -$15.2K | ﹤0.01% | 1939 |
|
2021
Q4 | $432K | Sell |
22,722
-81
| -0.4% | -$1.54K | ﹤0.01% | 1655 |
|
2021
Q3 | $759K | Sell |
22,803
-1,403
| -6% | -$46.7K | 0.01% | 1385 |
|
2021
Q2 | $939K | Buy |
24,206
+7,982
| +49% | +$310K | 0.01% | 1318 |
|
2021
Q1 | $782K | Sell |
16,224
-612
| -4% | -$29.5K | 0.03% | 723 |
|
2020
Q4 | $876K | Buy |
16,836
+693
| +4% | +$36.1K | 0.03% | 630 |
|
2020
Q3 | $432K | Buy |
16,143
+1,722
| +12% | +$46.1K | 0.02% | 917 |
|
2020
Q2 | $281K | Sell |
14,421
-145
| -1% | -$2.83K | 0.01% | 1142 |
|
2020
Q1 | $143K | Sell |
14,566
-729
| -5% | -$7.16K | ﹤0.01% | 1439 |
|
2019
Q4 | $170K | Buy |
15,295
+1,633
| +12% | +$18.2K | ﹤0.01% | 1674 |
|
2019
Q3 | $77K | Sell |
13,662
-107
| -0.8% | -$603 | ﹤0.01% | 1676 |
|
2019
Q2 | $119K | Buy |
+13,769
| New | +$119K | ﹤0.01% | 1675 |
|